| MeSH term | MeSH ID | Detail |
|---|---|---|
| Diarrhea | D003967 | 32 associated lipids |
| Pain | D010146 | 64 associated lipids |
| Abscess | D000038 | 13 associated lipids |
| Fractures, Spontaneous | D005598 | 4 associated lipids |
| Osteomyelitis | D010019 | 10 associated lipids |
| Alzheimer Disease | D000544 | 76 associated lipids |
| Intraoperative Complications | D007431 | 5 associated lipids |
| Drug Hypersensitivity | D004342 | 20 associated lipids |
| Hyperbilirubinemia | D006932 | 11 associated lipids |
| Anaphylaxis | D000707 | 35 associated lipids |
| Arthritis, Juvenile | D001171 | 8 associated lipids |
| Tuberculosis, Pulmonary | D014397 | 18 associated lipids |
| Synovitis | D013585 | 15 associated lipids |
| Arthralgia | D018771 | 8 associated lipids |
| Hemophilia A | D006467 | 10 associated lipids |
| Plaque, Amyloid | D058225 | 19 associated lipids |
| Gilbert Disease | D005878 | 2 associated lipids |
| Hydrarthrosis | D006833 | 1 associated lipids |
Rifamycin SV
Rifamycin SV is a lipid of Polyketides (PK) class. Rifamycin sv is associated with abnormalities such as Cholestasis, Infection, Dysentery, Soft Tissue Infections and Osteomyelitis. The involved functions are known as Uptake, Excretory function, Drug Kinetics, inhibitors and anaphylaxis. Rifamycin sv often locates in Hepatic, Blood, soluble, Entire gastrointestinal tract and Membrane. The associated genes with Rifamycin SV are SLCO1C1 gene, SLCO1B1 gene, ABCB11 gene and SLC10A1 gene.
Cross Reference
Introduction
To understand associated biological information of Rifamycin SV, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Rifamycin SV?
Rifamycin SV is suspected in Tuberculosis, Cholestasis, Infection, Dysentery, Soft Tissue Infections, Osteomyelitis and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Rifamycin SV
PubChem Associated disorders and diseases
What pathways are associated with Rifamycin SV
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Rifamycin SV?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Rifamycin SV?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Rifamycin SV?
There are no associated biomedical information in the current reference collection.
What genes are associated with Rifamycin SV?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Rifamycin SV?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Rifamycin SV
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Kono Y | Oxygen Enhancement of bactericidal activity of rifamycin SV on Escherichia coli and aerobic oxidation of rifamycin SV to rifamycin S catalyzed by manganous ions: the role of superoxide. | 1982 | J. Biochem. | pmid:6279585 |
| Amagai T et al. | The effect of ribavirin and rifamycin SV on age-dependent changes of the immune system during the adult life of SJL mice. | 1982 | Immunol. Lett. | pmid:6210629 |
| Revuz J et al. | [Generalization of zona in a nonimmunosuppressed patient receiving isoprinosine and rifamycin SV]. | 1983 | Ann Dermatol Venereol | pmid:6195953 |
| Xiao-Chang F et al. | Biochemical study of R-75-1, a new semi-synthetic rifamycin. | 1981 | J. Antibiot. | pmid:6168632 |
| Kradolfer F et al. | Chemotherapeutic activity of new derivatives of rifamycin. | 1966 | Antimicrob Agents Chemother (Bethesda) | pmid:5985258 |
| Okolicsanyi L et al. | [Effect of rifamycin SV on the metabolism of bile salts in the rat]. | 1979 Jan-Dec | G Ital Chemioter | pmid:554815 |
| Marchi E et al. | [New derivatives of rifamycin SV. Esters, hydrazide amides of 3-carboxyrifamycin SV]. | 1979 Jan-Dec | G Ital Chemioter | pmid:554811 |
| Gentile S et al. | [Influence of allopurinol on the half-life of tolbutamide and rifamycin-SV in blood of healthy volunteers]. | 1979 | Boll. Soc. Ital. Biol. Sper. | pmid:552849 |
| Nitti V | The antituberculous activity of rifamycin SV. | 1965 | Helv Med Acta | pmid:4958120 |
| Maggi N et al. | New derivatives of rifamycin SV. | 1965 | Antimicrob Agents Chemother (Bethesda) | pmid:4956802 |